Atea Pharmaceuticals (AVIR) Financials

$5.18

$-0.09 (-1.71%)

As on 10-Sep-2026 16:00EDT

Market cap

$468 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	192.18	351.37
Cost of Revenue	38.44	0.42	83.37	70.09	0.26	0.03
Gross Profit	-38.44	-0.42	-83.37	-70.09	-0.26	351.37
Operating Expenses	145.27	180.89	109.58	94.07	130.65	212.99
Operating Profit (EBIT)	-183.61	-180.89	-192.95	-164.16	-130.65	138.38
Other Income	--	--	--	--	--	0.21
Profit before Tax	-171.79	-164.51	-167.46	-134.94	-119.50	138.59
Provision for Tax	-6.50	-6.16	0.93	1.02	-3.59	17.40
Profit after Tax (Net Income)	-165.29	-158.35	-168.39	-135.96	-115.91	121.19
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-115.91	121.19

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	204.16	275.43	438.87	555.19	640.57	710.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	7.20	7.40	7.66	5.93
Current Liabilities	28.12	39.78	18.60	32.38	18.48	56.88
Total Liabilities	260.41	315.22	464.67	594.97	666.71	772.89

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.62	4.23	2.31	4.51	5.79	0.49
Current Assets	228.67	310.99	462.36	590.46	660.92	772.40
Total Assets	260.41	315.22	464.67	594.97	666.71	772.89
Total Debt*	0.42	0.84	1.64	2.40	3.12	0.20
Net Current Assets	200.54	271.21	443.75	558.08	642.44	715.52

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-132.03	-135.50	-85.40	-120.98	-87.01
Cash Flow from Investing Activities	--	188.79	56.11	40.30	-455.41	0.00
Cash from Financing Activities	--	-25.75	0.27	0.26	0.37	1.47
Net Cash Inflow / Outflow	--	--	--	--	--	-85.54

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.09	-2.03	-1.99	-1.63	-1.39	1.39
Cash EPS ($)	--	-2.02	-1.99	-1.62	-1.39	1.39
Adjusted Book Value ($)	--	3.53	5.20	6.65	7.69	8.15
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.69	-1.60	-1.02	-1.45	-1.00
Free Cash Flow per Share ($)	--	-1.69	-1.60	-1.02	-1.48	-1.00

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.18	-33.74	-22.64	-17.12	19.27
ROE (%)	-68.93	-44.34	-33.88	-22.74	-17.16	19.27
ROA (%)	-49.18	-40.61	-31.78	-21.55	-16.10	14.81
EBIT Margin (%)	--	--	--	--	-67.98	39.38
Net Margin (%)	--	--	--	--	-60.31	34.47
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.45	6.22
EBIT Growth (%)	-22.90	-24.43	-10.17	8.14	-194.42	1,354.55
Net Profit Growth (%)	-21.42	5.96	-23.85	-17.30	-195.64	1,207.06
EPS Growth (%)	-29.71	-0.02	-0.22	-0.17	-2.00	12.33
Book Value Growth (%)	-41.39	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.76	-1.68	-1.87	-3.46	6.42
Price / Book Value	2.16	1.01	0.64	0.46	0.63	1.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-260.47	0.13	1.29	2.69	5.38	0.10
Close Price ($)	4.65	3.57	3.35	3.05	4.81	8.94
High Price ($)	6.45	4.02	4.60	5.19	9.79	94.17
Low Price ($)	2.78	2.46	2.75	2.77	4.18	7.37
Market Cap ($ Cr)	467.59	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.00	0.00	0.00	0.00	0.00
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	8.13	7.82	24.85	18.24	35.77	13.58
Quick Ratio	8.13	--	--	--	--	--
Interest Coverage	--	--	--	--	-11.72	571.81

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	0.27	0.43
Receivable days	--	--	--	--	--	6.04
Inventory Days	--	--	--	--	--	--
Payable days	--	7,639.96	19.08	17.73	4,976.53	28,930.32
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.